Lucile Baseggio

Single-agent ibrutinib in RESONATE-2TM and RESONATETM versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia

2019 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové

Publikace